Michiel A. van de Sande, Professor (he/him/his)

Professor in Orthopedic Oncology
Princes Maxima Center for pediatric oncology and LUMC leiden
Utrecht / Leiden, Zuid-Holland, Netherlands

Disclosure information not submitted.

Presentation(s):

• Paper 26 - CLINICAL OUTCOME OF CURETTAGE IN ATYPICAL CARTILAGINOUS TUMOURS OF THE LONG BONES

  Thursday, November 14, 2024
  3:45 PM – 4:45 PM PST

• Paper 30 - EVALUATING PEEK, AND MOM LOCKING-MECHANISM SURVIVAL IN MUTARS KNEE RECONSTRUCTIONS FOR ONCOLOGICAL INDICATIONS: INSIGHTS FROM THE MUTARS ORTHOPEDIC REGISTRY EUROPE (MORE)

  Thursday, November 14, 2024
  3:45 PM – 4:45 PM PST

• Session 15: Desmoid Fibromatosis and TGCT

  Saturday, November 16, 2024
  3:30 PM – 4:30 PM PST

• Paper 105 - EFFICACY, SAFETY, AND PATIENT-REPORTED OUTCOMES OF VIMSELTINIB IN PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR: RESULTS FROM THE MOTION PHASE 3 TRIAL

  Saturday, November 16, 2024
  3:30 PM – 4:30 PM PST

• Paper 106 - SAFETY, EFFICACY, AND PATIENT-REPORTED OUTCOMES WITH VIMSELTINIB IN PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR WHO RECEIVED PRIOR ANTI-COLONY-STIMULATING FACTOR 1 THERAPY: ONGOING PHASE 2 STUDY

  Saturday, November 16, 2024
  3:30 PM – 4:30 PM PST